Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01666782 · ClinicalTrials.gov registry record · Phase 2
Study Comparing High-Dose Flu Vaccine to Standard Vaccine in Cancer Patients Less Than 65 Receiving Chemotherapy
A Phase 2 study of Cancer and Influenza Viral Infections, sponsored by Saad Jamshed MD.
- Completed
- Registry status
- Phase 2
- Development phase
- 105
- Enrollment target
- 2
- Study locations
NCT01666782: Completed Phase 2 study of Cancer and Influenza Viral Infections, sponsored by Saad Jamshed MD.
NCT01666782 is a Phase 2 study of Cancer and Influenza Viral Infections that has completed, run by Saad Jamshed MD. The registered enrollment target is 105 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01666782, a Phase 2 study of Cancer and Influenza Viral Infections, has completed, sponsored by Saad Jamshed MD.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 105 participants
- Enrollment target
- 2
- Study locations
Study Summary
The safety and immunogenicity of high dose influenza vaccine has not been studied in young patients receiving chemotherapy. This study will evaluate and compare the immunogenicity and safety of high dose influenza to standard dose influenza vaccine in adult oncology patients who are younger than 65 years old receiving chemotherapy.
Primary Outcome
Measure Hemagglutination Inhibition (HAI) Geometric Mean Titer (GMT) immunogenicity of high-dose (HD) and standard dose (SD) vaccine before and after vaccination at day 28.
Conditions Studied
Interventions
- BIOLOGICAL Standard Trivalent Influenza Vaccine
- BIOLOGICAL High-Dose Influenza Vaccine
Study Locations (2)
New York
- Rochester General Hospital - Rochester
- Lipson Cancer Center Linden Oaks Medical Campus - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2012-08 |
| Est. Completion | 2015-12 |
| Phase | Phase 2 |
What the finished NCT01666782 record still lists
NCT01666782 is an interventional study that assigns participants to a tested intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Standard Trivalent Influenza Vaccine is the first listed.
NCT01666782 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01666782 about?
NCT01666782 is a clinical study titled "Study Comparing High-Dose Flu Vaccine to Standard Vaccine in Cancer Patients Less Than 65 Receiving Chemotherapy". The safety and immunogenicity of high dose influenza vaccine has not been studied in young patients receiving chemotherapy. This study will evaluate and compare the immunogenicity and safety of high dose influenza to standard dose influenza vaccine in adult oncology patients who are younger than 65 ...
What is the current status of trial NCT01666782?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 105 participants. The study started on 2012-08. Estimated completion is 2015-12.
What conditions does trial NCT01666782 study?
This clinical trial studies the following conditions: Cancer, Influenza Viral Infections.
What interventions are being tested in trial NCT01666782?
The interventions under investigation include: Standard Trivalent Influenza Vaccine (BIOLOGICAL), High-Dose Influenza Vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT01666782?
This trial is sponsored by Saad Jamshed MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01666782 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01666782's enrollment target sits among peer trials
105 309th of 615 higher than 307 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
RECRUITING · Phase 2
-
CAncer TReatment INformed by the Molecular Tumor Board At Dartmouth
RECRUITING · Phase 2
-
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
RECRUITING · Phase 2
-
Acupuncture for People Experiencing Period Loss Due to Chemotherapy
RECRUITING · Phase 2
-
Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03372317 · 105 participants
Tau PET in Imaging and Cognition: Healthy Adults From 55-90
- NCT04253964 · 105 participants · Phase 2
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
- NCT04742452 · 105 participants · NA
Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears
- NCT04875429 · 105 participants · NA
Zenith® Fenestrated+ Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia